Research Repository

The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999–2007

Lichtenberg, Frank R (2013) The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999–2007. European Journal of Health Economics, 14 (1). pp. 41-56. ISSN 1618-7598

Full text for this resource is not available from the Research Repository.
Item Type: Article
Uncontrolled Keywords: orphan diseases; orphan drugs; drug approval; pharmaceutical innovation; econometric model
Subjects: Current > FOR Classification > 1402 Applied Economics
Current > FOR Classification > 1605 Policy and Administration
Historical > Faculty/School/Research Centre/Department > College of Business
SWORD Depositor: Symplectic Elements
Depositing User: Symplectic Elements
Date Deposited: 20 May 2020 04:22
Last Modified: 26 May 2020 00:14
URI: http://vuir.vu.edu.au/id/eprint/40451
DOI: https://doi.org/10.1007/s10198-011-0349-4
ePrint Statistics: View download statistics for this item
Citations in Scopus: 15 - View on Scopus

Repository staff only

View Item View Item

Search Google Scholar